Luvi Science Weekly Brief — a concise, research-focused update for Canadian women 40+ who prefer science with a calm, approachable tone.
Trending: Oral GLP-1 Research
Oral GLP-1 research continues to draw attention after recent publications on orforglipron, a small-molecule GLP-1 receptor agonist studied in clinical settings. For Luvi readers, the key takeaway is not hype — it is how quickly metabolic research is moving from injectable-only discussions toward more diverse study formats.
Education Highlight
If you are comparing peptide categories, terminology, and research references, start with the Luvi Peptide Library. It is a helpful reference point for browsing research categories and learning the language used across peptide-focused literature.
Research Tip
When reading wellness research, separate the compound being studied from the outcome being measured. Look for study design, population, endpoints, and limitations before drawing conclusions from headlines.
Explore Luvi
Continue your research browsing through the Luvi shop for current categories and educational product pages.
Disclaimer: Luvi Science content is for educational and research purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Products and information are not for human consumption or clinical use.